articleThe LancetApr 11, 2019Closed access

Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial

DADavid A. PalmaRORobert OlsonSHStephen HarrowSGStewart GaedeAVAlexander V. Louie

London Health Sciences Centre · Positive Living North · +8 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

1,843
total citations
FWCI
254.08
Percentile
100%
References
30
Citations per year

Authors

22

Topics & keywords

Topics
Keywords
  • SABR volatility model
  • Ablative case
  • Medicine
  • Radiation therapy
  • Standard of care
  • Open label
  • Palliative care
  • Radiosurgery
No related works found for this paper.

Funding